全文获取类型
收费全文 | 1216篇 |
免费 | 66篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 69篇 |
妇产科学 | 19篇 |
基础医学 | 222篇 |
口腔科学 | 19篇 |
临床医学 | 106篇 |
内科学 | 230篇 |
皮肤病学 | 40篇 |
神经病学 | 99篇 |
特种医学 | 102篇 |
外科学 | 152篇 |
综合类 | 43篇 |
一般理论 | 2篇 |
预防医学 | 51篇 |
眼科学 | 16篇 |
药学 | 72篇 |
中国医学 | 2篇 |
肿瘤学 | 47篇 |
出版年
2023年 | 12篇 |
2022年 | 19篇 |
2021年 | 61篇 |
2020年 | 25篇 |
2019年 | 37篇 |
2018年 | 16篇 |
2017年 | 27篇 |
2016年 | 23篇 |
2015年 | 37篇 |
2014年 | 59篇 |
2013年 | 66篇 |
2012年 | 86篇 |
2011年 | 88篇 |
2010年 | 60篇 |
2009年 | 43篇 |
2008年 | 59篇 |
2007年 | 53篇 |
2006年 | 40篇 |
2005年 | 46篇 |
2004年 | 29篇 |
2003年 | 30篇 |
2002年 | 18篇 |
2001年 | 22篇 |
2000年 | 20篇 |
1999年 | 8篇 |
1998年 | 23篇 |
1997年 | 25篇 |
1996年 | 15篇 |
1995年 | 19篇 |
1994年 | 16篇 |
1993年 | 19篇 |
1992年 | 13篇 |
1991年 | 17篇 |
1990年 | 9篇 |
1989年 | 17篇 |
1988年 | 14篇 |
1987年 | 11篇 |
1986年 | 13篇 |
1985年 | 14篇 |
1984年 | 6篇 |
1983年 | 4篇 |
1982年 | 14篇 |
1980年 | 9篇 |
1979年 | 8篇 |
1977年 | 8篇 |
1976年 | 7篇 |
1975年 | 9篇 |
1974年 | 3篇 |
1972年 | 5篇 |
1971年 | 4篇 |
排序方式: 共有1294条查询结果,搜索用时 15 毫秒
121.
122.
Transcutaneous electrical nerve stimulation (TENS) partially reduces primary hyperalgesia and is frequency dependent such that high frequency TENS produces approximately a 30% reduction in hyperalgesia whereas low frequency TENS has no effect. Both high and low frequency TENS completely reduce secondary hyperalgesia by activation of mu and delta- opioid receptors in the spinal cord and rostral-ventral medulla suggesting an opiate mediated analgesia. Clonidine in combination with opiates produces a synergistic interaction such that there is a potentiated reduction in hyperalgesia. Thus, we tested if combined application of clonidine with TENS would enhance the reduction in primary hyperalgesia. Male Sprague-Dawley rats were inflamed by subcutaneous injection of 3% carrageenan into one hindpaw. Withdrawal latency to radiant heat and withdrawal threshold to mechanical stimuli were assessed before and after inflammation and after administration of clonidine (0.002-2 mg/kg, intraperitoneal (i.p.)) with either low (4 Hz) or high (100 Hz) frequency TENS. Clonidine alone reduced both heat and mechanical hyperalgesia with ED50s of 0.02 and 1.0 mg/kg, respectively. In combination with either low or high frequency TENS, the dose-response curve shifted to the left and was significantly different from clonidine alone. The ED50s for heat and mechanical hyperalgesia following low frequency TENS with clonidine were 0.002 and 0.2 mg/kg, respectively and those following high frequency TENS with clonidine were 0.005 and 0.15 mg/kg, respectively. Thus, combined use of clonidine and TENS enhances the reduction in analgesia produced by TENS and enhances the potency of clonidine. It would thus be expected that one would reduce the side effects of clonidine and enhance analgesic efficacy with combinations of pharmaceutical and non-pharmaceutical treatments. 相似文献
123.
Lőrincz O Tőke ER Somogyi E Horkay F Chandran PL Douglas JF Szebeni J Lisziewicz J 《Nanomedicine : nanotechnology, biology, and medicine》2012,8(4):497-506
Here we characterize the structure, stability and intracellular mode of action of DermaVir nanomedicine that is under clinical development for the treatment of HIV/AIDS. This nanomedicine comprises pathogen-like pDNA/PEIm nanoparticles (NPs) having the structure and function resembling spherical viruses that naturally evolved to deliver nucleic acids to the cells. Atomic force microscopy demonstrated spherical 100 - 200 nm NPs with a smooth polymer surface protecting the pDNA in the core. Optical absorption determined both the NP structural stability and biological activity relevant to their ability to escape from the endosome and release the pDNA at the nucleus. Salt, pH and temperature influence nanomedicine shelf-life and intracellular stability. This approach facilitates the development of diverse polyplex nanomedicines where the delivered pDNA-expressed antigens induce immune responses to kill infected cells. FROM THE CLINICAL EDITOR: The authors investigated DermaVir nanomedicine comprised of pathogen-like pDNA/PEIm nanoparticles with structure and function resembling spherical viruses. DermaVir delivery of pDNA expresses antigens that induce immune responses to kill HIV infected cells. 相似文献
124.
125.
126.
127.
128.
A K Dosekun M R First P K Chandran K S Kant P Glas-Greenwalt M A Weiss J W Alexander V E Pollak 《Clinical nephrology》1982,18(2):101-105
Hyperacute and renal allograft failure, whether due to rejection or other mechanisms, such as perfusion injury, is usually associated with extensive intraglomerular fibrin deposition and allograft loss. Defibrination with ancrod was used to treat a patient with hyperacute renal allograft failure and extensive glomerular fibrin deposition and necrosis. The patient's plasma had normal fibrinolytic activity but a complete absence of the ability to generate prostacyclin-like activity from rat aortic endothelium "in vitro". Treatment was associated with complete recovery of renal function, disappearance of glomerular fibrin, and restoration toward normal of glomerular structure. 相似文献
129.
S. Elise Lawrence Mary Moss Chandran Jeong M. Park Helen Sweiss Thomas Jensen Palak Choksi Barrett Crowther 《Clinical transplantation》2023,37(3):e14922
Uncontrolled type 2 diabetes mellitus (T2DM) and post-transplant diabetes mellitus (PTDM) increase morbidity and mortality after kidney transplantation. Conventional strategies for diabetes management in this population include metformin, sulfonylureas, meglitinides and insulin. Limitations with these agents, as well as promising new antihyperglycemic agents, create a need and opportunity to explore additional options for transplant diabetes pharmacotherapy. Novel agents including sodium glucose co-transporter 2 inhibitors (SGLT2i), glucagon-like peptide-1 receptor agonists (GLP1RA), and dipeptidyl peptidase IV inhibitors (DPP4i) demonstrate great promise for T2DM management in the non-transplant population. Moreover, many of these agents possess renoprotective, cardiovascular, and/or weight loss benefits in addition to improved glucose control while having reduced risk of hypoglycemia compared with certain other conventional agents. This comprehensive review examines available literature evaluating the use of novel antihyperglycemic agents in kidney transplant recipients (KTR) with T2DM or PTDM. Formal grading of recommendations assessment, development, and evaluation (GRADE) system recommendations are provided to guide incorporation of these agents into post-transplant care. Available literature was evaluated to address the clinical questions of which agents provide greatest short- and long-term benefits, timing of novel antihyperglycemic therapy initiation after transplant, monitoring parameters for these antihyperglycemic agents, and concomitant antihyperglycemic agent and immunosuppression regimen management. Current experience with novel antihyperglycemic agents is primarily limited to single-center retrospective studies and case series. With ongoing use and increasing comfort, further and more robust research promises greater understanding of the role of these agents and place in therapy for kidney transplant recipients. 相似文献
130.
Pundir CS Rani K Garg P Chaudhary R Chandran P Kumari M 《Indian journal of medical sciences》2002,56(8):373-375
A quantitative chemical analysis of total cholesterol, bilirubin, calcium, inorganic phosphate and iron of three types of biliary calculi (cholesterol, pigment and mixed) of 40 gall stone former was carried out and correlated to with those of there sera. A moderately positive correlation for inorganic phosphate, Ca2+ and Fe2+ content of sera and calculi of cholesterol stone patient was found. A Good positive correlation for total cholesterol, a moderately positive correlation for bilirubin and iron but no correlation for inorganic phosphate and calcium content of sera and calculi of pigment stone patient was observed. A good moderately positive correlation for iron but no correlation for total cholesterol, bilirubin, inorganic phosphate and Ca2+ content of sera and calculi of stone patient was found. 相似文献